<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18433" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Bombesin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>LaPelusa</surname>
            <given-names>Andrew</given-names>
          </name>
          <aff>Charles R. Drew University of Medicine and Science</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jan</surname>
            <given-names>Arif</given-names>
          </name>
          <aff>Drexel University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew LaPelusa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arif Jan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18433.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Bombesin&#x000a0;(BBS, BB), is a 14-amino acid neurohormone polypeptide, derived initially from amphibians&#x000a0;with a wide range of physiological effects in the brain, lungs, and GI tract. Bombesin regulates gastrointestinal hormone release and gastrointestinal motility.<xref ref-type="bibr" rid="article-18433.r1">[1]</xref>&#x000a0;Recently, studies have evaluated the role of bombesin in tumor growth, cellular proliferation, and inflammation.<xref ref-type="bibr" rid="article-18433.r2">[2]</xref> Research has also discovered several peptides structurally related to bombesin.<xref ref-type="bibr" rid="article-18433.r3">[3]</xref>&#x000a0; Two well-studied homologs are called neuromedin B and gastrin-releasing peptide (GRP).<xref ref-type="bibr" rid="article-18433.r1">[1]</xref>&#x000a0; The gastrin-releasing peptide is biologically and immunologically&#x000a0;equivalent to bombesin, making GRP the mammalian equivalent. In addition to gastric neurohormonal impacts on the GI tract, the BN-like peptides have also been shown to modulate satiety, thermoregulation, glucose homeostasis, and circadian rhythms.<xref ref-type="bibr" rid="article-18433.r4">[4]</xref><xref ref-type="bibr" rid="article-18433.r5">[5]</xref></p>
      </sec>
      <sec id="article-18433.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>Bombesin receptors (BBR) are&#x000a0;G-protein-coupled receptors. These receptors classify into three different types.&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Neuromedin-B receptor ([NMB] also known as&#x000a0;bombesin receptor 1 [BRS1, BB1, BBR-1])</p>
          </list-item>
          <list-item>
            <p>Gastrin-releasing peptide receptor ([GRPR] also known as&#x000a0;bombesin receptor 2 [BRS1, BB2, BBR-2]).
<list list-type="bullet"><list-item><p>GRPR is expressed in the pancreas and at lower levels in the colon, breast, prostate, and skin.</p></list-item><list-item><p>Bombesin binding sites in the pancreas have a higher affinity for GRP and bombesin than compared to its other analog neuromedin B. This compares to the bombesin binding sites in the esophagus, which have a higher affinity to neuromedin B and bombesin than compared to GRP; this suggests that although bombesin has mammalian analogs, their true functions are not identical. The GRP-preferring binding sites were called "BB2" while the NMB-preferring binding sites were called "BB1".&#x000a0;GRP has a higher affinity for BBR-2 than for BBR-1, making it a promising target for directed cancer therapies.<xref ref-type="bibr" rid="article-18433.r6">[6]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Orphan receptor ([OR],&#x000a0;also known as&#x000a0;bombesin receptor 3 [BRS3, BB3, or BBR-3]).<xref ref-type="bibr" rid="article-18433.r7">[7]</xref>&#x000a0;&#x000a0;
<list list-type="bullet"><list-item><p>The bombesin receptor-3 (BBR-3):&#x000a0;The synthetic Bn peptide analog can be radiolabeled and used for binding studies in human tissues because it has a high affinity for human BRS-3.<xref ref-type="bibr" rid="article-18433.r8">[8]</xref><xref ref-type="bibr" rid="article-18433.r9">[9]</xref><xref ref-type="bibr" rid="article-18433.r10">[10]</xref>&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Bombesin has no known antagonist capability (i.e., receptor blocking effects). The area of the bombesin molecule that controls essential physiological activity also determines the affinity of the peptide toward its receptors. That is, the difference in potency amongst various derivatives and analogs of bombesin correlates with the variety in their receptor affinities. Of the segments and analogs of bombesin examined, none have been observed to occupy the bombesin receptor without causing a full biological response. Therefore, there remain no bombesin-related peptides that operate as a bombesin receptor antagonist.</p>
        <p>As a stimulatory peptide, bombesin's effects do have variable potency in their impacts. The essential physiological effect of bombesin-related peptides is attributed to the carboxy-terminal portion of the molecule.<xref ref-type="bibr" rid="article-18433.r11">[11]</xref><xref ref-type="bibr" rid="article-18433.r12">[12]</xref> Shortened carboxy-terminal variants of bombesin still maintain full inherent biological response, but their influences are less than that of primary bombesin.<xref ref-type="bibr" rid="article-18433.r11">[11]</xref><xref ref-type="bibr" rid="article-18433.r12">[12]</xref><xref ref-type="bibr" rid="article-18433.r13">[13]</xref><xref ref-type="bibr" rid="article-18433.r14">[14]</xref>&#x000a0;Bombesin receptors (and their analogs) are found in higher prevalence within breast, colon, lung, ovarian, urinary bladder, skin, and prostate tumors. Knowing this, researchers have attempted to target these receptors by using synthetic analogs of bombesin that are modified to contain chemotherapy agents (i.e., targeted chemotherapy).</p>
      </sec>
      <sec id="article-18433.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>It bears mentioning that bombesin is not structurally compatible with the biochemical processes because radioactive iodine (i.e., needed for biotech processes) normally binds to a tyrosine residue on the peptide of interest. Bombesin&#x02019;s primary structure conflicts with the radioactive iodine and hence renders bombesin incapable of creating a radioactive peptide. This fact is important because the radioactive peptide is what researchers use for receptor binding studies. This issue is also true of all peptides structurally related to bombesin, thus potential use in radioactive labeling may not be possible.<xref ref-type="bibr" rid="article-18433.r15">[15]</xref><xref ref-type="bibr" rid="article-18433.r16">[16]</xref></p>
      </sec>
      <sec id="article-18433.s4" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Bombesin binds to G protein-coupled receptors, which stimulate adenylate cyclase, increasing intracellular cyclic adenine monophosphate (cAMP) levels and activating intracellular signal cascades. These cascades propagate, leading to calcium, sodium, and potassium fluxes inducing the modulation of growth factor receptors, and expression of the proto-oncogenes c-fos and c-myc.<xref ref-type="bibr" rid="article-18433.r17">[17]</xref>. When bound to G-cells, bombesin signal transduction ultimately produces phosphatidylinositol, which acts as a secondary messenger, mediating intracellular vesicular fusion with the plasma membrane, and therefore regulating gastrin secretion from G-cells in the antrum of the stomach.<xref ref-type="bibr" rid="article-18433.r18">[18]</xref><xref ref-type="bibr" rid="article-18433.r19">[19]</xref>&#x000a0;</p>
        <p>Bombesin G protein-coupled receptor signal-cascade also results in the activation of protein kinase C (PKC) through the phosphatidylinositol second-messenger system.<xref ref-type="bibr" rid="article-18433.r17">[17]</xref>&#x000a0;Bombesin and bombesin-like peptides can activate protein kinase C proteins by endogenous diacylglycerol(DAG) levels; this increases the synthesis of cellular cyclic guanosine monophosphate (cGMP) molecules enabling the mobilization of intracellular calcium. Intracellular calcium activates the intracellular signal cascade mechanism controlling hormone secretion.<xref ref-type="bibr" rid="article-18433.r6">[6]</xref>&#x000a0;&#x000a0;</p>
        <p>Bombesin-associated extracellular events include stimulation of mitogenesis and monocyte chemoattraction.<xref ref-type="bibr" rid="article-18433.r20">[20]</xref> A study showed evidence of bombesin&#x02019;s mitogenic capabilities was whereby vasopressin caused desensitization to the mitogenic action of bombesin mediated by uncoupling the receptor from its signaling system.<xref ref-type="bibr" rid="article-18433.r17">[17]</xref><xref ref-type="bibr" rid="article-18433.r20">[20]</xref> Therefore the localization of these receptors is preassumed to be positioned on the basolateral side of the cell plasma membrane. There remain no studies that have localized receptors for bombesin or structurally associated peptides.</p>
      </sec>
      <sec id="article-18433.s5" sec-type="Function">
        <title>Function</title>
        <p>In the brain, bombesin is known as neuromedin B and is involved in smooth muscle contraction.<xref ref-type="bibr" rid="article-18433.r21">[21]</xref>&#x000a0;Bombesin is present in regions of the trachea, bronchus, and within the whole lung at different stages of human fetal development. Bombesin is present in neonates, children, and adults.<xref ref-type="bibr" rid="article-18433.r22">[22]</xref>&#x000a0;</p>
        <p>Bombesin causes the release of endogenous gastrin, activating sensory neurons located in the gastric fundus responsible for gastric smooth muscle motility and luminal protection. Activation of sensory neurons causes increased production of nitric oxide through activation of constitutive nitric oxide synthase. Activation of nitric oxide synthase leads to an increase in gastric mucosal blood flow and makes the stomach less susceptible to injury from luminal irritants.<xref ref-type="bibr" rid="article-18433.r23">[23]</xref> Bombesin is the most effective promotor of G cell-regulated gastrin release plus subsequent stimulation of gastric acid excretion.<xref ref-type="bibr" rid="article-18433.r16">[16]</xref><xref ref-type="bibr" rid="article-18433.r24">[24]</xref><xref ref-type="bibr" rid="article-18433.r25">[25]</xref><xref ref-type="bibr" rid="article-18433.r24">[24]</xref></p>
        <p>Bombesin is predominantly known to regulate homeostasis within the gastrointestinal tract.<xref ref-type="bibr" rid="article-18433.r1">[1]</xref>&#x000a0;When binding to gastrointestinal luminal receptors, bombesin produces adverse effects such as nausea, vomiting, and diarrhea. Bombesin is the major source of negative feedback signals that stop eating behavior second only to cholecystokinin.<xref ref-type="bibr" rid="article-18433.r26">[26]</xref>&#x000a0;</p>
        <p>Bombesin can function as a growth factor through autocrine or paracrine mechanisms, which may modulate the growth of various benign and neoplastic tissues. Therefore, the problem this protein can address is that of prostate precision. The fact that radiolabeling cannot differentiate between benign hyperplastic prostate cells and malignant carcinoma cells limits their diagnostic value. Hence, there has been much effort put into developing new prostate carcinoma&#x02013;specific PET tracers with high diagnostic sensitivity and specificity.<xref ref-type="bibr" rid="article-18433.r27">[27]</xref><xref ref-type="bibr" rid="article-18433.r28">[28]</xref></p>
      </sec>
      <sec id="article-18433.s6" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Bombesin binds to the G-protein receptor. G protein-coupled reaction occurs, which activates a phosphorylation cascade. Phosphorylation cascade cleaves PIP2. PIP2 separates into inosine-monophosphate (IP3) and diacylglycerol (DAG). IP3 and DAG both increase in concentration within the cell. DAG interacts with protein kinase C (PKC). DAG-PKC interaction activates protein kinase C (aPKC). aPKC phosphorylates serine residues on intracellular target proteins.<xref ref-type="bibr" rid="article-18433.r29">[29]</xref>&#x000a0;Intracellular target proteins release calcium stores intracellularly. &#x000a0;Intracellular calcium levels increase, causing cellular depolarization. Intracellular calcium binds to synapsin, altering its conformation. Altered synapsin causes intracellular vesicle diffusion. Altered synapsin exposes calcium-binding sites on microtubules attached to intracellular vesicles. Calcium activates dynein arms causing efferent microtubules diffusion. Vesicles fuse with the plasma membrane and release their contents into the extracellular environment.<xref ref-type="bibr" rid="article-18433.r29">[29]</xref></p>
      </sec>
      <sec id="article-18433.s7" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Researchers believe that neuropeptides influence feeding, satiety, energy homeostasis, and other parameters associated with weight control.<xref ref-type="bibr" rid="article-18433.r30">[30]</xref>&#x000a0;Those involved are bombesin, insulin, and orexins. These peptides exhibit diverse effects upon the hypothalamus by acting as ligands for G protein-coupled receptors within the brain. Some tumors can produce agents such as bombesin and adrenocorticotropic hormone, which can affect caloric processing.<xref ref-type="bibr" rid="article-18433.r31">[31]</xref><xref ref-type="bibr" rid="article-18433.r32">[32]</xref><xref ref-type="bibr" rid="article-18433.r33">[33]</xref> The abnormal intake and utilization of calories contribute to the altered metabolism associated with cachexic states precipitated by tumorigenesis, which leads to a cyclical chain of events in which protein catabolism, glucose intolerance, and lipolysis cannot be augmented by the addition of calories.</p>
        <p>Inhalational exposures can precipitate an inflammatory reaction within the airways and alveoli, leading to activated neutrophils, and other inflammatory cells release proteases as part of the inflammatory process. Neutrophil-induced oxidative damage stimulates the release of profibrotic neuropeptide bombesin in the normal process of tissue repair. This mechanism appears to contribute to the pulmonary neuroendocrine cells' promotion of bombesin-like peptide immunoreactivity.<xref ref-type="bibr" rid="article-18433.r34">[34]</xref></p>
        <p>Studies have&#x000a0;correlated bombesin-like immunoreactivity with the abnormal inflammatory&#x000a0;response seen in bronchopulmonary dysplasia.<xref ref-type="bibr" rid="article-18433.r35">[35]</xref><xref ref-type="bibr" rid="article-18433.r36">[36]</xref>&#x000a0;Researchers in a study of 132 infants at 28-weeks gestation or less found that bombesin-like peptide levels elevate in the urine prior to the development of bronchopulmonary dysplasia.<xref ref-type="bibr" rid="article-18433.r37">[37]</xref>&#x000a0;Infants who had elevated levels of the bombesin-like peptide in their urine 1 to 4 days after birth were ten times more likely to develop bronchopulmonary dysplasia.<xref ref-type="bibr" rid="article-18433.r37">[37]</xref>&#x000a0;Therefore, urine bombesin-like peptide screening might allow for early therapeutic interventions to minimize disease progression.</p>
        <p>Eosinophilic granuloma is a fibrotic lung disease almost always seen in adult cigarette smokers. One study showed that the number of pulmonary neuroendocrine cells with bombesin-like immunoreactivity increases in patients with eosinophilic granuloma.<xref ref-type="bibr" rid="article-18433.r20">[20]</xref>&#x000a0;Therefore neuroendocrine cell hyperplasia may lead to bombesin-like peptide elevation and subsequent monocyte and fibroblast recruitment, which contribute to granuloma formation; this would be in line with other studies which have shown bombesin to be chemotactic for monocytes and mitogenic for fibroblasts.<xref ref-type="bibr" rid="article-18433.r20">[20]</xref></p>
        <p>Inhibition of Ca ++ influx inhibits the release of neurotransmitters like bombesin, acetylcholine, norepinephrine, serotonin, somatostatin, and substance P. These neurotransmitters mediate pain perception in the spinal cord. Inhibition of release into the synaptic cleft leads to decreased postsynaptic neuronal firing and transmission of nociception.<xref ref-type="bibr" rid="article-18433.r38">[38]</xref></p>
        <p>Tumors of neuronal origin such as medulloblastoma, primitive neuroectodermal tumors, neuroblastoma, pineoblastoma are bombesin positive. Recently it has been suggested that bombesin-related peptides are involved in the autocrine stimulation of human small-cell lung carcinomas The growth and metastatic potential of neuroendocrine tumors.&#x000a0;The molecular mechanisms and signaling pathways that are responsible for bombesin-like peptide-induced cell migration and invasion remain unclear.<xref ref-type="bibr" rid="article-18433.r23">[23]</xref><xref ref-type="bibr" rid="article-18433.r39">[39]</xref></p>
        <p>Bombesin exerts a stimulatory effect on the growth of human prostatic cancer cells in vitro.<xref ref-type="bibr" rid="article-18433.r34">[34]</xref>&#x000a0;Bombesin also has a role in prostatic epithelium growth; this would support other studies stating that prostatic carcinoma may have an endocrine, autocrine, or paracrine proliferation stimulus within the gland microenvironment.<xref ref-type="bibr" rid="article-18433.r40">[40]</xref><xref ref-type="bibr" rid="article-18433.r41">[41]</xref><xref ref-type="bibr" rid="article-18433.r42">[42]</xref>&#x000a0;This important fact provides an objective basis for the development of neuropeptides as therapeutic targets and may be helpful in the treatment of advanced prostatic carcinoma.<xref ref-type="bibr" rid="article-18433.r43">[43]</xref><xref ref-type="bibr" rid="article-18433.r41">[41]</xref></p>
      </sec>
      <sec id="article-18433.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Loss of bombesin receptors correlates with age-dependent obesity, hypertension, glucose intolerance, and high insulin levels. This expanded adipose deposition may, in part, be due to a decline in energy consumption without a shift in eating or movement, which infers that bombesin receptors may signify a plausible target upon which notable advancement can take place in the realm of anti-obesity agents.</p>
        <p>Bombesin has the theoretical capability to address prostate cancer screening. Current screening methods include prostate-specific antigen serum testing, followed by a digital rectal examination. Those screening techniques do not yield information on the primary location of the carcinoma cells. Therefore, possible metastases cannot be determined or diagnosed with high accuracy. The fact that radiolabeling cannot differentiate between benign hyperplastic prostate cells and malignant carcinoma cells limits their diagnostic value. BBR and gastrin-releasing peptide receptors are over-expressed in solid malignancies and particularly in prostate cancer.<xref ref-type="bibr" rid="article-18433.r44">[44]</xref>&#x000a0;These receptors are over-expressed rarely and, if expressed, then only in low density in benign prostatic hyperplasia and normal prostate tissue.<xref ref-type="bibr" rid="article-18433.r45">[45]</xref>&#x000a0;Studies have shown that prostate tissue has a high density of receptors belonging to the bombesin receptor family.<xref ref-type="bibr" rid="article-18433.r46">[46]</xref> This finding has sparked an interest in developing new prostate carcinoma&#x02013;specific PET tracers, which would provide high diagnostic sensitivity and specificity.</p>
        <p>Precision medicine is also known as theranostics, is a medical model that separates people into different groups with medical care tailored to the individual patient based on their predicted response or risk of disease.<xref ref-type="bibr" rid="article-18433.r47">[47]</xref>&#x000a0;Gastrin-releasing peptide receptor antagonists have promise in theranostics of several highly incident tumors, including prostate and breast.<xref ref-type="bibr" rid="article-18433.r48">[48]</xref>&#x000a0;Bombesin receptors often demonstrate significant expression on a variety of tumors. Therefore, bombesin can chaperone cytotoxic drugs straight to these tumors. A cytotoxic analog of bombesin containing doxorubicin displayed disease stabilization through phase-I clinical trials against ovarian and endometrial carcinomas.<xref ref-type="bibr" rid="article-18433.r49">[49]</xref> It is now undergoing phase-I or phase-II clinical trials in other various malignancies.<xref ref-type="bibr" rid="article-18433.r4">[4]</xref>&#x000a0;</p>
        <p>Measuring bombesin stimulated gastrin response can serve as a marker for patients who are at very high risk for gastric cancer. Patients with late-onset hypogammaglobulinemia are at very high risk for gastric cancer. Late-onset hypogammaglobulinemia patients have reduced secretion of gastrin after stimulation with bombesin. Stimulated gastrin response can, therefore, be useful as a marker for this type of immunodeficiency. Plasma gastrin responses to stimulation with bombesin correlate with late-onset hypogammaglobulinemia. (72% sensitivity , 100% specificity). Bombesin can help to distinguish late-onset hypogammaglobulinemia from X-linked agammaglobulinemia, early-onset hypogammaglobulinemia, and lymphoproliferative cancer.<xref ref-type="bibr" rid="article-18433.r50">[50]</xref>&#x000a0;This differentiation would also help to identify patients with an increased risk for gastric cancer. Plasma gastrin responses to stimulation with bombesin correlate with late-onset hypogammaglobulinemia.&#x000a0;</p>
        <p>A&#x000a0;bombesin/gastrin-releasing peptide antagonist might hold promise as a possible new agent for the treatment of breast cancer.<xref ref-type="bibr" rid="article-18433.r51">[51]</xref></p>
      </sec>
      <sec id="article-18433.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18433&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18433">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18433/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18433">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18433.s10">
        <title>References</title>
        <ref id="article-18433.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anastasi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erspamer</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bucci</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Isolation and amino acid sequences of alytesin and bombesin, two analogous active tetradecapeptides from the skin of European discoglossid frogs.</article-title>
            <source>Arch Biochem Biophys</source>
            <year>1972</year>
            <month>Feb</month>
            <volume>148</volume>
            <issue>2</issue>
            <fpage>443</fpage>
            <page-range>443-6</page-range>
            <pub-id pub-id-type="pmid">4537042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moreno</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mantey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Ramos-&#x000c1;lvarez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Moody</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.</article-title>
            <source>Peptides</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>101</volume>
            <fpage>213</fpage>
            <page-range>213-226</page-range>
            <pub-id pub-id-type="pmid">29410320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>J&#x000f6;rnvall</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vagne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghatei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Mutt</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>1979</year>
            <month>Sep</month>
            <day>12</day>
            <volume>90</volume>
            <issue>1</issue>
            <fpage>227</fpage>
            <page-range>227-33</page-range>
            <pub-id pub-id-type="pmid">496973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Accardo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mannucci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nicolato</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vurro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Diaferia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bontempi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marzola</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morelli</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells.</article-title>
            <source>Drug Deliv Transl Res</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>215</fpage>
            <page-range>215-226</page-range>
            <pub-id pub-id-type="pmid">30569349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assimakopoulos</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Alexandris</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Scopa</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Mylonas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Thomopoulos</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Georgiou</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Nikolopoulou</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Vagianos</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats.</article-title>
            <source>World J Gastroenterol</source>
            <year>2005</year>
            <month>Nov</month>
            <day>21</day>
            <volume>11</volume>
            <issue>43</issue>
            <fpage>6757</fpage>
            <page-range>6757-64</page-range>
            <pub-id pub-id-type="pmid">16425380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Moody</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Igarashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-64</page-range>
            <pub-id pub-id-type="pmid">18185064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Battey</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Way</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Corjay</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Shapira</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kusano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Harkins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Slattery</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1991</year>
            <month>Jan</month>
            <day>15</day>
            <volume>88</volume>
            <issue>2</issue>
            <fpage>395</fpage>
            <page-range>395-9</page-range>
            <pub-id pub-id-type="pmid">1671171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sainz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Akeson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Pradhan</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Searles</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Spindel</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Battey</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.</article-title>
            <source>J Biol Chem</source>
            <year>1997</year>
            <month>Oct</month>
            <day>10</day>
            <volume>272</volume>
            <issue>41</issue>
            <fpage>26062</fpage>
            <page-range>26062-71</page-range>
            <pub-id pub-id-type="pmid">9325344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moreno</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mantey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Nuche-Berenguer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reitman</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.</article-title>
            <source>J Pharmacol Exp Ther</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>347</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <page-range>100-16</page-range>
            <pub-id pub-id-type="pmid">23892571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pradhan</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Katsuno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Mantey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Donohue</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sainz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Battey</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.</article-title>
            <source>Eur J Pharmacol</source>
            <year>1998</year>
            <month>Feb</month>
            <day>19</day>
            <volume>343</volume>
            <issue>2-3</issue>
            <fpage>275</fpage>
            <page-range>275-87</page-range>
            <pub-id pub-id-type="pmid">9570477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deschodt-Lanckman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Robberecht</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Neef</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lammens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christophe</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues.</article-title>
            <source>J Clin Invest</source>
            <year>1976</year>
            <month>Oct</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>891</fpage>
            <page-range>891-8</page-range>
            <pub-id pub-id-type="pmid">184111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Battey</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Spindel</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Benya</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.</article-title>
            <source>Pharmacol Rev</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>60</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-42</page-range>
            <pub-id pub-id-type="pmid">18055507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broccardo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Falconieri Erspamer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Melchiorri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Castiglione</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Relative potency of bombesin-like peptides.</article-title>
            <source>Br J Pharmacol</source>
            <year>1975</year>
            <month>Oct</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-7</page-range>
            <pub-id pub-id-type="pmid">1201380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Mantey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.</article-title>
            <source>Eur J Pharmacol</source>
            <year>1995</year>
            <month>Dec</month>
            <day>27</day>
            <volume>294</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-69</page-range>
            <pub-id pub-id-type="pmid">8788416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swope</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Schonbrunn</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Characterization of ligand binding and processing by bombesin receptors in an insulin-secreting cell line.</article-title>
            <source>Biochem J</source>
            <year>1987</year>
            <month>Nov</month>
            <day>01</day>
            <volume>247</volume>
            <issue>3</issue>
            <fpage>731</fpage>
            <page-range>731-8</page-range>
            <pub-id pub-id-type="pmid">2827637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cardona</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bleehen</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Reeve</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line.</article-title>
            <source>Biochem J</source>
            <year>1992</year>
            <month>Jan</month>
            <day>01</day>
            <volume>281 ( Pt 1)</volume>
            <issue>Pt 1</issue>
            <fpage>115</fpage>
            <page-range>115-20</page-range>
            <pub-id pub-id-type="pmid">1310003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rozengurt</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Bombesin stimulation of mitogenesis. Specific receptors, signal transduction, and early events.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>142</volume>
            <issue>6 Pt 2</issue>
            <fpage>S11</fpage>
            <page-range>S11-5</page-range>
            <pub-id pub-id-type="pmid">2174658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campos</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Buchan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meloche</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Pederson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Gastrin secretion from human antral G cells in culture.</article-title>
            <source>Gastroenterology</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-44</page-range>
            <pub-id pub-id-type="pmid">1971610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meloche</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Signal transduction events involved in bombesin-stimulated gastrin release from human G cells in culture.</article-title>
            <source>Can J Physiol Pharmacol</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>72</volume>
            <issue>9</issue>
            <fpage>1060</fpage>
            <page-range>1060-5</page-range>
            <pub-id pub-id-type="pmid">7842388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguayo</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Waldron</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sherritt</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>YE</given-names>
              </name>
            </person-group>
            <article-title>Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.</article-title>
            <source>J Clin Invest</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>838</fpage>
            <page-range>838-44</page-range>
            <pub-id pub-id-type="pmid">2394833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minamino</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sudoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kangawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsuo</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Neuromedins: novel smooth-muscle stimulating peptides identified in porcine spinal cord.</article-title>
            <source>Peptides</source>
            <year>1985</year>
            <volume>6 Suppl 3</volume>
            <fpage>245</fpage>
            <page-range>245-8</page-range>
            <pub-id pub-id-type="pmid">3841690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghatei</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Henzen-Logman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blank</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Polak</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Bombesin and vasoactive intestinal polypeptide in the developing lung: marked changes in acute respiratory distress syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1983</year>
            <month>Dec</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>1226</fpage>
            <page-range>1226-32</page-range>
            <pub-id pub-id-type="pmid">6630415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Eskra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Taglia</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Blunier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>QT</given-names>
              </name>
              <name>
                <surname>Benya</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Gastrin-releasing peptide signaling alters colon cancer invasiveness via heterochromatin protein 1Hs&#x003b2;.</article-title>
            <source>Am J Pathol</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>178</volume>
            <issue>2</issue>
            <fpage>672</fpage>
            <page-range>672-8</page-range>
            <pub-id pub-id-type="pmid">21281799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delle Fave</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Annibale</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de Magistris</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Severi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bruzzone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Puoti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Melchiorri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Torsoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erspamer</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Bombesin effects on human GI functions.</article-title>
            <source>Peptides</source>
            <year>1985</year>
            <volume>6 Suppl 3</volume>
            <fpage>113</fpage>
            <page-range>113-6</page-range>
            <pub-id pub-id-type="pmid">3913904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ladenheim</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Salorio</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Mantey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Characterization of bombesin binding sites in the rat stomach.</article-title>
            <source>Eur J Pharmacol</source>
            <year>1997</year>
            <month>Jan</month>
            <day>29</day>
            <volume>319</volume>
            <issue>2-3</issue>
            <fpage>245</fpage>
            <page-range>245-51</page-range>
            <pub-id pub-id-type="pmid">9042597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erspamer</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Improta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Melchiorri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sopranzi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Evidence of cholecystokinin release by bombesin in the dog.</article-title>
            <source>Br J Pharmacol</source>
            <year>1974</year>
            <month>Oct</month>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-32</page-range>
            <pub-id pub-id-type="pmid">4451817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherman</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Dorisio</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>O'Dorisio</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Howe</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.</article-title>
            <source>Surgery</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>154</volume>
            <issue>6</issue>
            <fpage>1206</fpage>
            <page-range>1206-13; discussion 1214</page-range>
            <pub-id pub-id-type="pmid">24238043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rick</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Abi-Chaker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Szalontay</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jaszberenyi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jayakumar</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shamaladevi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Szepeshazi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vidaurre</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Halmos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Krishan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Schally</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2013</year>
            <month>Feb</month>
            <day>12</day>
            <volume>110</volume>
            <issue>7</issue>
            <fpage>2617</fpage>
            <page-range>2617-22</page-range>
            <pub-id pub-id-type="pmid">23359692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Evers</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Banker</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Hellmich</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Bombesin-mediated AP-1 activation in a human gastric cancer (SIIA).</article-title>
            <source>Surgery</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>130</fpage>
            <page-range>130-6; discussion 136-7</page-range>
            <pub-id pub-id-type="pmid">8751574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anubhuti</surname>
              </name>
            </person-group>
            <article-title>Role of neuropeptides in appetite regulation and obesity--a review.</article-title>
            <source>Neuropeptides</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>375</fpage>
            <page-range>375-401</page-range>
            <pub-id pub-id-type="pmid">16935329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuchihashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yanaihara</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.</article-title>
            <source>Jpn J Clin Oncol</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>232</fpage>
            <page-range>232-7</page-range>
            <pub-id pub-id-type="pmid">1359172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Travis</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Linnoila</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Tsokos</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Hitchcock</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Nieman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pass</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Doppman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1991</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>529</fpage>
            <page-range>529-53</page-range>
            <pub-id pub-id-type="pmid">1709558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>BU</given-names>
              </name>
              <name>
                <surname>Fachnie</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Mellinger</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Janakiraman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Malignant somatostatinoma presenting with diabetic ketoacidosis.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1987</year>
            <month>May</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>609</fpage>
            <page-range>609-21</page-range>
            <pub-id pub-id-type="pmid">2822297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Wobken</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Landrum</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Changes in bombesin, calcitonin, and serotonin immunoreactive pulmonary neuroendocrine cells in cystic fibrosis and after prolonged mechanical ventilation.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1988</year>
            <month>Jan</month>
            <volume>137</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-31</page-range>
            <pub-id pub-id-type="pmid">3337452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramaniam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bausch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Twomey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andreeva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoder</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Crapo</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cuttitta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sunday</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2007</year>
            <month>Nov</month>
            <day>01</day>
            <volume>176</volume>
            <issue>9</issue>
            <fpage>902</fpage>
            <page-range>902-12</page-range>
            <pub-id pub-id-type="pmid">17585105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramaniam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Weller</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sunday</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia?</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2003</year>
            <month>Sep</month>
            <day>01</day>
            <volume>168</volume>
            <issue>5</issue>
            <fpage>601</fpage>
            <page-range>601-11</page-range>
            <pub-id pub-id-type="pmid">12807697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cullen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Marter</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Allred</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parad</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sunday</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2002</year>
            <month>Apr</month>
            <day>15</day>
            <volume>165</volume>
            <issue>8</issue>
            <fpage>1093</fpage>
            <page-range>1093-7</page-range>
            <pub-id pub-id-type="pmid">11956050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>ZQ</given-names>
              </name>
              <name>
                <surname>Huo</surname>
                <given-names>FQ</given-names>
              </name>
              <name>
                <surname>Jeffry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hampton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Demehri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>ZC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Turkoz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cornelius</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Kopan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Battey</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ZF</given-names>
              </name>
            </person-group>
            <article-title>Chronic itch development in sensory neurons requires BRAF signaling pathways.</article-title>
            <source>J Clin Invest</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>123</volume>
            <issue>11</issue>
            <fpage>4769</fpage>
            <page-range>4769-80</page-range>
            <pub-id pub-id-type="pmid">24216512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Integrin &#x003b2;1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion.</article-title>
            <source>Surgery</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>154</volume>
            <issue>2</issue>
            <fpage>369</fpage>
            <page-range>369-75</page-range>
            <pub-id pub-id-type="pmid">23889963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohlsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fred&#x000e4;ng</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Axelson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.</article-title>
            <source>Scand J Gastroenterol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>1224</fpage>
            <page-range>1224-9</page-range>
            <pub-id pub-id-type="pmid">10636070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robertson</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hardcastle</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer.</article-title>
            <source>Int J Cancer</source>
            <year>1995</year>
            <month>Sep</month>
            <day>27</day>
            <volume>63</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-75</page-range>
            <pub-id pub-id-type="pmid">7558455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anastasi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erspamer</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bucci</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes.</article-title>
            <source>Experientia</source>
            <year>1971</year>
            <month>Feb</month>
            <day>15</day>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-7</page-range>
            <pub-id pub-id-type="pmid">5544731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salido</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vilches</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roomans</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.</article-title>
            <source>Cancer</source>
            <year>2002</year>
            <month>Jan</month>
            <day>15</day>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>368</fpage>
            <page-range>368-77</page-range>
            <pub-id pub-id-type="pmid">11900223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rousseau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Uribe</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Zeisler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>B&#x000e9;nard</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue.</article-title>
            <source>ACS Omega</source>
            <year>2019</year>
            <month>Jan</month>
            <day>31</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>1470</fpage>
            <page-range>1470-1478</page-range>
            <pub-id pub-id-type="pmid">30775647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markwalder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reubi</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.</article-title>
            <source>Cancer Res</source>
            <year>1999</year>
            <month>Mar</month>
            <day>01</day>
            <volume>59</volume>
            <issue>5</issue>
            <fpage>1152</fpage>
            <page-range>1152-9</page-range>
            <pub-id pub-id-type="pmid">10070977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bologna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Festuccia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Muzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Biordi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ciomei</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bombesin stimulates growth of human prostatic cancer cells in vitro.</article-title>
            <source>Cancer</source>
            <year>1989</year>
            <month>May</month>
            <day>01</day>
            <volume>63</volume>
            <issue>9</issue>
            <fpage>1714</fpage>
            <page-range>1714-20</page-range>
            <pub-id pub-id-type="pmid">2539244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baratto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jadvar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iagaru</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.</article-title>
            <source>Mol Imaging Biol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>501</fpage>
            <page-range>501-509</page-range>
            <pub-id pub-id-type="pmid">29256046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gnesin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cicone</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mitsakis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Van der Gucht</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baechler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miralbell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garibotto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Zilli</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Prior</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist <sup>68</sup>Ga-NODAGA-MJ9.</article-title>
            <source>EJNMMI Res</source>
            <year>2018</year>
            <month>Dec</month>
            <day>12</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>108</fpage>
            <pub-id pub-id-type="pmid">30543050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keller</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schally</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Nagy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Halmos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.</article-title>
            <source>Cancer</source>
            <year>2005</year>
            <month>Nov</month>
            <day>15</day>
            <volume>104</volume>
            <issue>10</issue>
            <fpage>2266</fpage>
            <page-range>2266-74</page-range>
            <pub-id pub-id-type="pmid">16211544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>den Hartog</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>van Furth</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lamers</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Decreased gastrin secretion in patients with late-onset hypogammaglobulinemia.</article-title>
            <source>N Engl J Med</source>
            <year>1988</year>
            <month>Jun</month>
            <day>16</day>
            <volume>318</volume>
            <issue>24</issue>
            <fpage>1563</fpage>
            <page-range>1563-7</page-range>
            <pub-id pub-id-type="pmid">3374528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18433.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pinski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Szepeshazi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Halmos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Radulovic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Groot</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schally</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.</article-title>
            <source>Cancer</source>
            <year>1994</year>
            <month>Feb</month>
            <day>15</day>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>1229</fpage>
            <page-range>1229-38</page-range>
            <pub-id pub-id-type="pmid">8313327</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
